Drug In Focus articles are published by GenericsWeb based on its proprietary Ark Patent Intelligence that analyse opportunities in launching generic versions of branded drugs. These articles contain a detailed patent landscape analysis of the branded drug.

Based on the monthly update for Ark Expiry Database product, and written in conjunction with the good people at Generics Bulletin, Pipeline Watch contains a list of molecules with data exclusivity and SPC expiries in the month ahead, a list of potential development targets, and some brief commentary.